Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1200 participants.
Also called NCT06645522
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,200 participants
- Sponsor
- Registry
-
NCT06645522
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06645522. Randomized; quadruple masking; primary purpose treatment. Start 2024-10-30 (anticipated); primary completion 2026-10-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Edaravone dexborneol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Yi Yang
Record details
- Record id
cardio:ct-nct06645522- Content hash
98d231e3ad174a1f96edc77266b342eab29ca47ec99c03840e631fab4ea023e6